IDH3A and neoplasm: Accurate intraoperative identification of glioma molecular subtypes, such as isocitrate dehydrogenase mutation and 1p/19q co-deletion, is essential for precise diagnosis, prognostication, and determining the extent of tumor resection—balancing maximal tumor removal with preservation of neurological function.